AI assistant
INSMED Inc — Director's Dealing 2022
Aug 10, 2022
30150_dirs_2022-08-10_47b07d47-1a30-41f2-a2cb-c525ad476f95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-08-08
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-08 | Common Stock | M | 24430 | $3.40 | Acquired | 24430 | Indirect |
| 2022-08-08 | Common Stock | S | 24430 | $27.67 | Disposed | 0 | Indirect |
| 2022-08-08 | Common Stock | M | 6200 | $3.40 | Acquired | 6200 | Indirect |
| 2022-08-08 | Common Stock | S | 6200 | $28.45 | Disposed | 0 | Indirect |
| 2022-08-08 | Common Stock | M | 161193 | $4.55 | Acquired | 161193 | Indirect |
| 2022-08-08 | Common Stock | S | 161193 | $27.75 | Disposed | 0 | Indirect |
| 2022-08-08 | Common Stock | M | 24977 | $4.55 | Acquired | 24977 | Indirect |
| 2022-08-08 | Common Stock | S | 24977 | $28.43 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-08 | Stock Option (right to buy) | $3.4 | M | 30630 | Disposed | 2022-09-10 | Common Stock (30630.0) | Indirect |
| 2022-08-08 | Stock Option (right to buy) | $4.55 | M | 186170 | Disposed | 2022-09-28 | Common Stock (186170.0) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 256716 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020
F3: This is the weighted average sales price representing 24,430 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 6,200 shares sold at prices ranging from $28.26 to $28.73 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 161,193 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 24,977 shares sold at prices ranging from $28.26 to $28.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.